Ipca Laboratories Ltd
₹1636.30
(0.63%)
Wed, 27 May 2026, 02:09 pm
Health Technology
Pharmaceuticals: Major
24.5KIpca Laboratories Share Price Live Chart
1 Day
(0.63%)
No Result Found
Summary
Market Cap
39988.86
Net Profit
787.53
P/B
5.48
Sector P/E
34.32
P/E
51.63
EV/EBITDA
24.19
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
13.61
ROCE
17.12
Debt/Equity
0.21
EPS (TTM)
41.57
Dividend Yield
0.25
Book Value
292.74
Interest Cover
15.85
Analysis
all
- Ipca Laboratories's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Ipca Laboratories's earnings are expected to exceed the low risk growth rate next year.
- Performance (ROE) is expected to be above the current IN Pharmaceuticals industry average.
- An improvement in Ipca Laboratories's performance (ROE) is expected over the next 3 years.
- Ipca Laboratories's revenue growth is expected to exceed the India market average.
- Ipca Laboratories is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Ipca Laboratories's dividends as it is not paying a notable one for India.
- No need to calculate the sustainability of Ipca Laboratories's dividends in 3 years as they are not expected to pay a notable one for India.
- Ipca Laboratories is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Ipca Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 44.72 | 44.72 | 44.72 | 44.72 | 44.72 |
| FII | 10.63 | 10.63 | 10.42 | 10.67 | 10.76 |
| DII | 37.45 | 37.32 | 36.77 | 36.20 | 36.06 |
| Public | 7.20 | 7.33 | 8.08 | 8.40 | 8.46 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1933.63 | 1727.63 | 1629.27 | 1521.63 | 1423.27 | 1315.63 | 1109.63 |
| Fibonacci | 1727.63 | 1648.94 | 1600.33 | 1521.63 | 1442.94 | 1394.33 | 1315.63 |
| Camarilla | 1587.55 | 1568.67 | 1549.78 | 1521.63 | 1512.02 | 1493.13 | 1474.25 |
Pivots Level: Classic
R3
+412
1933.63
R2
+206
1727.63
R1
+107.63
1629.27
S1
-98.37
1423.27
S2
-206
1315.63
S3
-412
1109.63
Moving Average
Period
Value
10-EMA
1589.77
20-EMA
1574.98
30-EMA
1561.46
50-EMA
1542.04
100-EMA
1508.53
200-EMA
1471.28
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 13 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 11 Jul 2025 | agm | ||
| 05 Jul 2025 | dividend | Final Dividend - Rs. - 2 | 05 Aug 2025 |
| 29 May 2025 | dividend | ₹2.00 Dividend /Share | 05 Aug 2025 |
| 14 Nov 2024 | dividend | ₹2.00 Dividend /Share | 27 Nov 2024 |
| 27 Oct 2024 | dividend | Interim Dividend - Rs. - 2 | 27 Nov 2024 |
| 17 Jul 2024 | agm | ||
| 06 Jul 2024 | dividend | Annual General Meeting/Dividend - Rs 2 Per Share | 07 Aug 2024 |
| 29 May 2024 | dividend | ₹2.00 Dividend /Share | 07 Aug 2024 |
Peer Comparison
Ipca Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Cipla Ltd
Ipca Laboratories Ltd About
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical Ingredients (APIs). The Company is an integrated pharmaceutical company manufacturing and marketing.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1949
Headquarters
CEO
Premchand Godha
Employees
Contact
Website
http://www.ipca.com
investors@ipca.com ; ipca@ipca.com
Phone
91-22-66474444
Location
48 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| USHA MADHUKAR CHANDURKAR | bulk | Sell | 4000000 | 1501.52 | 18 Dec 2024 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 158841 | 867.55 | 14 Nov 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 158841 | 867.55 | 14 Nov 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 158842 | 927.15 | 03 Nov 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 158842 | 927.15 | 03 Nov 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 68372 | 900.35 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 148105 | 900.35 | 25 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 148105 | 900.35 | 25 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 68372 | 900.35 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 232725 | 889.45 | 17 Oct 2022 |